 open-label study high-dose intravenous immunoglobulin severe childhood asthma Eight pediatric patients severe steroid-dependent asthma open-label trial high-dose intravenous immunoglobulin IVIG attempt steroid requirements Monthly therapy high-dose IVIG threefold decrease maintenance oral corticosteroid dose extra oral corticosteroids control exacerbations asthma significant improvements peak expiratory flow rates symptom-score rating immunomodulatory effect IVIG changes immediate skin test reactivity Seven patients reactions panel allergens therapy course trial progressive diminution skin test reactivity reduction sensitivity completion months therapy preliminary study reduction steroid requirements improvement symptoms flow measurements diminution immediate skin test reactivity support potential role IVIG treatment severe steroid-dependent asthma randomized trial